(ISMD) Inspire Small/Mid Cap Impact - Overview
Etf: Equities, Mid-Cap, Small-Cap, Index
Dividends
| Dividend Yield | 1.27% |
| Yield on Cost 5y | 1.57% |
| Yield CAGR 5y | -38.64% |
| Payout Consistency | 79.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.9% |
| Relative Tail Risk | -5.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.47 |
| Alpha | -1.80 |
| Character TTM | |
|---|---|
| Beta | 0.887 |
| Beta Downside | 0.900 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.64% |
| CAGR/Max DD | 0.39 |
Description: ISMD Inspire Small/Mid Cap Impact January 02, 2026
The Inspire Small/Mid Cap Impact ETF (NYSE ARCA: ISMD) is designed to track an index that selects U.S.-listed small- and mid-cap equities with an “Inspire Impact Score” of 0 or higher. The fund commits at least 80 % of its net assets to the index’s component securities, thereby providing investors with exposure to companies that meet a minimum impact-screening threshold while remaining focused on the small-blend style category.
Key supplemental metrics (as of the most recent filing):
• Expense ratio ≈ 0.45 %-moderately low for a niche impact-focused ETF, but higher than broad-market small-cap ETFs that often sit near 0.10 %.
• Assets under management (AUM) ≈ $120 million, indicating a relatively thin market and potential liquidity constraints for large trades.
• Top sector allocations are typically Technology (≈ 30 %), Consumer Discretionary (≈ 20 %) and Healthcare (≈ 15 %). These sectors are sensitive to U.S. consumer confidence and labor-market dynamics, which have been volatile in 2024 due to shifting monetary policy.
Assumption: The sector weights remain stable because the index methodology rebalances quarterly; however, rapid changes in impact-score assessments could shift exposure more quickly than anticipated, adding a layer of uncertainty to sector risk forecasts.
If you want a data-driven deep-dive into ISMD’s risk-return profile, the ValueRay platform offers granular analytics that can help you validate whether this impact-oriented small-cap play fits your portfolio objectives.
What is the price of ISMD shares?
Over the past week, the price has changed by +3.26%, over one month by +6.18%, over three months by +14.81% and over the past year by +12.72%.
Is ISMD a buy, sell or hold?
What are the forecasts/targets for the ISMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 46.4 | 8.4% |
ISMD Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 253.8m USD (253.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 253.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 253.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.18% (E(253.8m)/V(253.8m) * Re(9.18%) + (debt-free company))
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)